TECTONIC THERAPEUTIC, INC. Basic Shares Outstanding (Weighted Average)
TECTONIC THERAPEUTIC, INC. (TECX) reported Basic Shares Outstanding (Weighted Average) of 18.96 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-06
- TECTONIC THERAPEUTIC, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 18.96M shares, a 1.52% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 18.77M shares, a 9.39% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 18.72M shares, a 26.17% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 18.71M shares, a 27.05% increase year-over-year.
- TECTONIC THERAPEUTIC, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 18.32M shares, a 115.81% increase from fiscal 2024.
- TECTONIC THERAPEUTIC, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 8.49M shares, a 569.30% increase from fiscal 2023.
- TECTONIC THERAPEUTIC, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 1.27M shares, a 97.10% decline from fiscal 2022.
- TECTONIC THERAPEUTIC, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 43.74M shares, a 101965.15% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 18.96M shares 10-Q · filed 2026-08-06 | 18.87M shares 10-Q · filed 2026-08-06 | 18.82M shares derived: average of 3 quarters · filed 2026-08-06 | 18.79M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 18.77M shares 10-Q · filed 2026-05-07 | 18.75M shares derived: average of 2 quarters · filed 2026-05-07 | 18.73M shares derived: average of 3 quarters · filed 2026-05-07 | 18.72M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 18.72M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 18.72M shares derived: average of 2 quarters · filed 2026-02-26 | 18.71M shares derived: average of 3 quarters · filed 2026-08-06 | 18.32M shares 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | 18.71M shares 10-Q · filed 2025-11-06 | 18.70M shares derived: average of 2 quarters · filed 2026-08-06 | 18.19M shares 10-Q · filed 2025-11-06 | 17.35M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 18.68M shares 10-Q · filed 2026-08-06 | 17.92M shares 10-Q · filed 2026-08-06 | 16.89M shares derived: average of 3 quarters · filed 2026-08-06 | 16.35M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | 17.16M shares 10-Q · filed 2026-05-07 | 16.00M shares derived: average of 2 quarters · filed 2026-05-07 | 15.58M shares derived: average of 3 quarters · filed 2026-05-07 | 12.41M shares derived: average of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | 14.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | 14.78M shares derived: average of 2 quarters · filed 2026-02-26 | 10.83M shares derived: average of 3 quarters · filed 2026-02-26 | 8.49M shares 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | 14.73M shares 10-Q · filed 2025-11-06 | 8.82M shares derived: average of 2 quarters · filed 2025-11-06 | 6.37M shares 10-Q · filed 2025-11-06 | 5.09M shares derived: average of 4 quarters · filed 2025-11-06 | ||||
| 2024-06-30 | 2.92M shares 10-Q · filed 2025-08-07 | 2.15M shares 10-Q · filed 2025-08-07 | 1.88M shares derived: average of 3 quarters · filed 2025-08-07 | 1.74M shares derived: average of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | 1.39M shares 10-Q · filed 2025-05-08 | 44.79M shares 10-Q · filed 2024-05-09 | 1.36M shares derived: average of 2 quarters · filed 2025-05-08 | 1.35M shares derived: average of 3 quarters · filed 2025-05-08 | 1.32M shares derived: average of 4 quarters · filed 2025-05-08 | |||
| 2023-12-31 | 1.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 1.33M shares derived: average of 2 quarters · filed 2025-03-20 | 1.29M shares derived: average of 3 quarters · filed 2025-03-20 | 1.27M shares 10-K · filed 2025-03-20 | 44.33M shares 10-K · filed 2024-03-14 | |||
| 2023-09-30 | 1.32M shares 10-Q · filed 2024-11-12 | 44.53M shares 10-Q · filed 2023-11-09 | 1.27M shares derived: average of 2 quarters · filed 2024-11-12 | 1.25M shares 10-Q · filed 2024-11-12 | 44.23M shares 10-Q · filed 2023-11-09 | 22.59M shares derived: average of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | 1.23M shares 10-Q · filed 2024-08-14 | 44.13M shares 10-Q · filed 2023-08-10 | 1.21M shares 10-Q · filed 2024-08-14 | 44.09M shares 10-Q · filed 2023-08-10 | 29.69M shares derived: average of 3 quarters · filed 2024-08-14 | 33.21M shares derived: average of 4 quarters · filed 2024-08-14 | ||
| 2023-03-31 | 44.04M shares 10-Q · filed 2024-05-09 | 44.04K shares 10-Q · filed 2023-05-11 | 43.91M shares derived: average of 2 quarters · filed 2024-05-09 | 43.87M shares derived: average of 3 quarters · filed 2024-05-09 | 43.82M shares derived: average of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | 43.79M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 43.78M shares derived: average of 2 quarters · filed 2024-03-14 | 43.75M shares derived: average of 3 quarters · filed 2024-03-14 | 43.74M shares 10-K · filed 2024-03-14 | 43.74K shares 10-K · filed 2023-03-23 | |||
| 2022-09-30 | 43.77M shares 10-Q · filed 2023-11-09 | 43.77K shares 10-Q · filed 2022-11-08 | 43.73M shares derived: average of 2 quarters · filed 2023-11-09 | 43.72M shares 10-Q · filed 2023-11-09 | 43.72K shares 10-Q · filed 2022-11-08 | 21.89M shares derived: average of 4 quarters · filed 2023-11-09 | ||
| 2022-06-30 | 43.70M shares 10-Q · filed 2023-08-10 | 43.70K shares 10-Q · filed 2022-08-09 | 43.70M shares 10-Q · filed 2023-08-10 | 43.70K shares 10-Q · filed 2022-08-09 | 14.59M shares derived: average of 3 quarters · filed 2023-08-10 | 10.96M shares derived: average of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | 43.70K shares 10-Q · filed 2023-05-11 | 43.67K shares derived: average of 2 quarters · filed 2023-05-11 | 43.66K shares derived: average of 3 quarters · filed 2023-05-11 | 43.37K shares derived: average of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | 43.65K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | 43.64K shares derived: average of 2 quarters · filed 2023-03-23 | 43.26K shares derived: average of 3 quarters · filed 2023-03-23 | 42.85K shares 10-K · filed 2023-03-23 | ||||
| 2021-09-30 | 43.62K shares 10-Q · filed 2022-11-08 | 43.07K shares derived: average of 2 quarters · filed 2022-11-08 | 42.59K shares 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | 42.51K shares 10-Q · filed 2022-08-09 | 42.07K shares 10-Q · filed 2022-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |